S A Hill

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

G. Dark, S A Hill, Vivien E. Prise et al. · PubMed · 1997 · 624 citations

Vascular Shutdown, Tumor Biology, Oncology +16

Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate.

David J. Chaplin, George R. Pettit, S A Hill · PubMed · 1999 · 252 citations

Pathology, Biomedical Engineering, Metronomic Chemotherapy +19

Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts

Moritz A. Konerding, W Malkusch, B Klapthor et al. · British Journal of Cancer · 1999 · 216 citations · Full text

Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents.

D J Chaplin, George R. Pettit, C.S. Parkins et al. · PubMed · 1996 · 118 citations

Antivascular Approaches, Blood Flow Reduction, Drug Targeting +15

Next Generation of Zinc Bisguanidine Polymerization Catalysts towards Highly Crystalline, Biodegradable Polyesters

Alina Hermann, S A Hill, Angela Metz et al. · Angewandte Chemie International Edition · 2020 · 96 citations · Full text